Nayana Prabhu

Agency for Science, Technology and Research — Singapore

Medicine · Health Sciences

26h-index4.6kcitations69works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(10), Computational Drug Discovery Methods(8), EFL/ESL Teaching and Learning(6), Immune Cell Function and Interaction(6), Respiratory viral infections research(6)

Publications69 total

Bioactive compounds from marine algae in pancreatic cancer therapy: mechanistic insights into fucoidan and phlorotannins: a review
Medical Oncology·2025· 3 cited
MS CETSA deep functional proteomics uncovers DNA repair programs leading to gemcitabine resistance
Nature Communications·2025· 2 citedOpen Access
Abstract LB088: MS-CETSA deep functional proteomics uncovers a new induced DNA-repair programs leading to resistance to DNA-damaging drugs
Cancer Research·2025
ATR Inhibition and Replication Stress Converge on a BCL6-Mediated Reversal of the Dark Zone Signature in DLBCL
Blood·2024· 1 cited
Proteome-wide CETSA reveals diverse apoptosis-inducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery
Cell Reports·2024· 4 citedOpen Access
MS-CETSA functional proteomics uncovers new DNA-repair programs leading to Gemcitabine resistance
2024Open Access
Hybrid Model Design For Protein Function Prediction
2024
Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development
Cell chemical biology·2024· 19 cited
Abstract 211: Applying cellular thermal shift assays to uncover novel regulators of epithelial to mesenchymal transition in triple negative breast cancer
Cancer Research·2024
Deep learning based CETSA feature prediction cross multiple cell lines with latent space representation
Scientific Reports·2024· 6 citedOpen Access
Deep learning enables the discovery of a novel cuproptosis-inducing molecule for the inhibition of hepatocellular carcinoma
Acta Pharmacologica Sinica·2023· 21 citedOpen Access
Deep Learning Based CETSA Feature Prediction cross Multiple Cell Lines with Latent Space Representation
Research Square (Research Square)·2023Open Access
CETSA Feature Based Clustering for Protein Outlier Discovery by Protein-to-Protein Interaction Prediction
2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC)·2022· 2 cited
CycleDNN - A Novel Deep Neural Network Model for CETSA Feature Prediction cross Cell Lines
2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC)·2022· 2 cited
Abstract 1130: CETSA interaction proteomics define specific RNA modification pathways as key components of fluorouracil based cancer drug cytotoxicity
Cancer Research·2022
Identification of an inhibitory pocket in falcilysin bound by chloroquine provides a new avenue for malaria drug development
2022Open Access
Identification of an Inhibitory Pocket in Falcilysin Bound by Chloroquine Provides a New Avenue for Malaria Drug Development
SSRN Electronic Journal·2022Open Access
CETSA interaction proteomics define specific RNA-modification pathways as key components of fluorouracil-based cancer drug cytotoxicity
Cell chemical biology·2021· 47 cited
Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development
2021· 18 citedOpen Access
Recent advances in proteome‐wide label‐free target deconvolution for bioactive small molecules
Medicinal Research Reviews·2021· 33 cited
page 1 of 4Next →

Frequent Co-authors

P. Nordlund(20), Lingyun Dai(16), Radoslaw M. Sobota(11), Ka Diam Go(7), Yan Ting Lim(7), Mookkan Prabakaran(7), Jimmy Kwang(7), Han Yu(5), D.M. Kemeny(5), Hui-Ting Ho(5), Lekshmy Sreekumar(4), Jerzy M. Dziekan(4), Grennady Wirjanata(4), Andreas Larsson(4), Zbynek Bozdech(4), Qiang Jia(4), Fang He(4), Wai Leong Tam(4), Xavier Bisteau(3), Johan Lengqvist(3)